9 Results for "

MK0476

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "MK0476" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-13315
CAS No.: 151767-02-1
Purity:  99.84%
Synonyms: MK0476
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology Cancer

Montelukast sodium (MK0476) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast sodium decreases eosinophil infiltration into the asthmatic airways. Montelukast sodium can also be used for COVID-19 research .
loading...
    loading...
15
15 Publications Verification
Cat. No.: HY-13315A
CAS No.: 158966-92-8
Purity:  99.94%
Synonyms: MK0476 free base
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology Cancer

Montelukast (MK0476 free base) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast can be used for the reseach of asthma and liver injury. Montelukast also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast decreases eosinophil infiltration into the asthmatic airways. Montelukast can also be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-13315B
CAS No.: 577953-88-9
Synonyms: MK0476 dicyclohexylamine
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology Cancer

Montelukast (MK0476) dicyclohexylamine is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast dicyclohexylamine can be used for the reseach of asthma and liver injury. Montelukast dicyclohexylamine also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast dicyclohexylamine decreases eosinophil infiltration into the asthmatic airways. Montelukast dicyclohexylamine can also be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-13315AR
CAS No.: 158966-92-8
Synonyms: MK0476 free base (Standard)
Montelukast (Standard) is the analytical standard of Montelukast. This product is intended for research and analytical applications. Montelukast (MK0476 free base) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast can be used for the reseach of asthma and liver injury. Montelukast also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast decreases eosinophil infiltration into the asthmatic airways. Montelukast can also be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-13315R
CAS No.: 151767-02-1
Synonyms: MK0476 (Standard)
Montelukast (sodium) (Standard) is the analytical standard of Montelukast (sodium). This product is intended for research and analytical applications. Montelukast sodium (MK0476) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast sodium decreases eosinophil infiltration into the asthmatic airways. Montelukast sodium can also be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-13315BR
CAS No.: 577953-88-9
Synonyms: MK0476 dicyclohexylamine (Standard)
Montelukast (dicyclohexylamine) (Standard) is the analytical standard of Montelukast (dicyclohexylamine). This product is intended for research and analytical applications. Montelukast (MK0476) dicyclohexylamine is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast dicyclohexylamine can be used for the reseach of asthma and liver injury. Montelukast dicyclohexylamine also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast dicyclohexylamine decreases eosinophil infiltration into the asthmatic airways. Montelukast dicyclohexylamine can also be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-13315C
CAS No.: 220927-27-5
Synonyms: (S)-MK0476; (S)-Montelukast
Target:  

Drug Intermediate

Research Areas:  

Others

Montelukast impurity 2 ((S)-MK0476) is an impurity of Montelukast.
loading...
    loading...
Cat. No.: HY-13315S1
CAS No.: 2673270-26-1
Synonyms: MK0476-d6
Montelukast-d6 (sodium) is the deuterium labeled Montelukast (sodium). Montelukast sodium is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (Cysltr1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage .
loading...
    loading...
Cat. No.: HY-13315S
CAS No.: 1093746-29-2
Synonyms: MK0476-d6 free acid
Montelukast-d6 is the deuterium labeled Montelukast (sodium). Montelukast sodium is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (Cysltr1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage .
loading...
    loading...